# Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris

> **NCT01930175** · PHASE2 · TERMINATED · sponsor: **Novartis Pharmaceuticals** · enrollment: 13 (actual)

## Conditions studied

- Pemphigus Vulgaris

## Interventions

- **DRUG:** VAY736
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01930175
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12-18
- **Primary completion:** 2019-09-25
- **Final completion:** 2019-09-25
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** The study recruitment was terminated in Dec-2015 for strategic reasons related to the development of the compound.
- **Last updated:** 2021-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01930175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01930175, "Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01930175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*